chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 40 year old female patient who on approximately 26-JUL-2010 "about 1 week ago" was vaccinated with the first dose of GARDASIL (Lot#: not reported). The physician stated that on an unspecified date "a few days post vaccination", the patient developed swollen lymph nodes in her neck. The patient sought unspecified medical attention. At the time of the report the patient's outcome was unknown. Follow-up information was received from an other health professional concerning a 39 year old female patient who on 16-JUL-2010, was vaccinated in the left deltoid with the first dose of GARDASIL (Lot#: 663559/1178Y) at 11:00 am. There was no illness at the time of vaccination. Subsequently on 28-JUL-2010, one week after the first injection, the patient experienced swollen lymph nodes in neck. The patient did not seek medical attention. At the time of the report the patient's outcome was unknown. No further information is available.
Developed dizziness evening after shot; day after had temp to 103 degrees-dizziness-tingling-all over not localized to injection site.
Guillian Barre Syndrome; started evening following vaccine and progressed requiring hospitalization; diagnosed 2 days following vaccine
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 15-SEP-2015, the patient was vaccinated with the third dose of improperly stored oral, ROTATEQ (lot # L000571, expiration date 26-JUL-2016) (dose unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
1 day after Varivax developed large (6cm x 8cm) area of erythema, induration. 4cm x 3cm honey colored caused lesion in center
Went to the clinic received vaccine on 10/31/2005, injection was given in my left arm. 20-30 min after vaccination I noticed swelling and extreme pain to left arm. Tues 11/01/2005 started having a severe rash and severe pain to left arm. Still having pain in left arm fever and aches. Unknown- reported by patient
Fever over 102 degrees F, chills, severe arm pain & swelling at site, warmth at site, persistent edema of entire right upper arm & severe pain 7 days post vaccination, on antibiotics for presumed cellulitis, received IM steroids.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2022 at 6:47 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 25-Jan-2022 at 6:47 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment medications were reported.   This case was linked to MOD-2022-542869 (Patient Link).
Pt described having a "silver dollar sized itchy solid red circular blotch" on her left arm at the injection site. No other side effects reports.
Dizziness, Headache, Myalgia, NauseaVomiting, malaise Narrative:
pt recv vax 25MAR96 & w/in 48hr pt devel a large local rxn, described as size of a dessert plate;pt also exp warmth, itching, aching, fever 101, & lump under the axilla;MD prescribed pred & ATB;
Numbness in left arm, tingling in left leg and a heavy feeling in left lower leg with decreased strength in left leg.
Tingling in lower arm and hand that lasted from time of vaccine until the following morning.; This is a spontaneous report from a non-contactable other health care professional. A 30-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 20Dec2020 13:00 at SINGLE DOSE at right arm for COVID 19 immunization. Medical history included allergies: sulfa drugs. The patient's concomitant medications were not reported.  On 20Dec2020 13:00, the patient experienced Tingling in lower arm and hand that lasted from time of vaccine until the following morning. The patient did not receive treatment. No COVID prior vaccination. The patient has not been tested for COVID-19 since the vaccination. The event was assessed as non-serious. The outcome of the event was recovered.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Shakiness-Medium, Additional Details: PATIENT WAITED IN THE WAITING AREA FOR 10 MIN AND LEFT TO REST ROOM. MOM REACHED OUT TO RPH REPORTING THAT HER SON SAT DOWN OUT SIDE OT THE BATH ROOM DOOR AND IS SHAKING AND NERVOUS. RPH ATTENDED CHECKED PULSE AND PATIENT WAS RESPONSIVE AND BREATHING. HE WAS ANXIOUS AND CRYING. CALLED 911 , PARAMEDICS CHECKED AND REPORTED NORMAL BP. MOM REFUSED FURTHER EVALUATION AND MENTIONED TO PARAMEDICS THAT HER SON HAVE ANXIETY AND IT HAS NOTHING TO DO WITH VACCINE. SHE REFUSED TO GO TO HOSPITAL.
Breakthrough COVID- August 2021; sore throat, headache, fatigue; tested at urgent care-- 2-3 days of not feeling well, quarantined for 10 days feel fine now
Golf ball sized painful, itchy swelling for 2 weeks post-injection, dime sized painful swelling for a week after that, and now pea-sized hard lump remains at injection site
Pain subsequent to injection in right upper extremity in area of lower deltoid "Dull to severe ache" worse with use. 1st reported on 10-23-07. Unresponsive to Advil, Tylenol, Lipoderm patch, Neurontin and Capsaicin cream.
Arthralgia, Diarrhea, fatigue Narrative:  missed a day of work
There was some swell up there; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A male patient received bnt162b2 (BNT162B2), administration date 24Aug2021 (Lot number: FC3180) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing), notes: Other medical conditions: Reporter stated, "No.". There were no concomitant medications. The following information was reported: SWELLING (non-serious) with onset 24Aug2021, outcome "not recovered", described as "There was some swell up there". Therapeutic measures were not taken as a result of swelling.  Additional information Date of adverse event: Reporter stated, 24Aug we have taken the vaccine in the evening, Like, we only took the vaccine around nighttime, Like, there was some swell up there, Like, We were giving some little bit ice pad and things like that. It was there for like a day or two. We didn't gave much, It's quite normal, Then we left it. Now it was there, Like continuously. The problem is from the day of vaccine. Lab test: Reporter stated, No. Concern: Reporter stated, Actually, like my wife did a vaccine like on 24Aug with (withheld) so, it's almost like 9 days, What I am seeing here is Like, she is still having you know, swelling on her hand with reddish thing so, It's like, I am not sure like, It's truly like, When I took a vaccine. It's like, it was there for 1 or day then, it went away, Everything fine.   Follow-up attempts are completed. No further information is expected.
Vaccine frozen rather than refrigerated. Dose administered. Offered revaccination. Wants new booster, not revax
Right hand swollen - multiple joints swollen & painful left ankle, left elbow, right wrist.
Headache, Myalgia, Arthralgia, Fever, soreness at injection site Narrative:  Soreness at injection site
Painful 'dead-arm' effect within 1-2hours, lasting 2 days. Approximately 7-8 days after injection, developed slightly raised red welts/chill-blains on hands (fingers, palm and back of hand) and feet (ties and heels). Welts were 'hot' and intensely itchy for 2 days and then painful on the 3rd day before fading. Treated with hydrocortisone cream.
Pt described vomiting, blurry vision, fatigue. (I asked if it could be food poisoning and pt stated they had eaten Mexican food at a restaurant after they received the vaccination).
Approx 15 mins post injection, right arm heaviness and pain. Then extreme fatigue, vagal stimulus when stood up, vasovagal near syncope, diaphoretic. Approx 18-20 mins after injection throat and tongue tingling and swelling.  PO liquid diphenhydramine 50mg given at that time. Then taken to ER for further observation. In the ER, right arm did lock up. No further treatment given.
temp to 103;shaking uncontrollable hand & feet-blue & mottled;
This case was reported by a nurse and described the occurrence of an injection site reaction in a 5 year old pt who received Infanrix. On 8/25/04, the pt received the 5th dose of Infanrix in the left arm (lot DTPA622A2). At an unspecified time following the 5th administration of Infanrix, in 8/04, the pt experienced an injection site reaction at the site of Infanrix administration characterized as swollen, inflammed, warm and sore. The pt was seen in the ER and was treated with antibiotics and Benadryl. The event was ongoing at the time of initial reporting. The nurse considered the event to probably be related to vaccination with Infanrix. The nurse stated that she became aware of this pt "only by word of mouth. No formal complaint; pt not seen."
COVID 19; COVID 19; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid received from 13Oct2023 to 18Oct2023. The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
15 minutes post vax, complaint of itching all over body, no rashes noted. Treatment Benadry.l
This spontaneous report as received from a healthcare professional refers to a patient of unknown age and gender who on 11-AUG-2014 was vaccinated with GARDASIL, 0.5 ml, intramuscular. The healthcare worker reported that GARDASIL that underwent a temperature excursion has been administered. No adverse effect reported. No further information was provided. The outcome of GARDASIL that underwent a temperature excursion has been administered was unknown. The reporter considered incorrect product storage to be not related to GARDASIL. This is one of several reports received from same source. Additional information has been requested.
Patient had some swelling of her arm; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (Patient had some swelling of her arm) in a 78-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included Kidney disorder (Patient had for 17 plus years but under control).    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Patient had some swelling of her arm). At the time of the report, PERIPHERAL SWELLING (Patient had some swelling of her arm) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
incorrect route of administration, with no reported adverse event; Initial information received on 22-Apr-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient who experienced incorrect route of administration, with no reported adverse event while receiving vaccine yellow fever vaccine [yf-vax].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect yellow fever vaccine solution for injection (lot number, expiry date : not reported) via unknown route in unknown administration site for immunization.  On an unknown date, the patient experienced incorrect route of administration, with no reported adverse event (incorrect route of product administration) (unknown latency) following the administration of yellow fever vaccine.  Action taken : Not applicable.  Corrective treatment : Not reported for the event (incorrect route of administration, with no reported adverse event).  Outcome : Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Fever, maculo-papular skin rashes (all over) 5 days after receiving MMR, VARIVAX vaccines and diarrhea. ADVIL given.
Family documented DOB incorrectly so vaccine Truemba administered before age of 16 as well as booster 6 months later.
L upper arm has been red and swollen at the vaccine site.  Erythema present when he returned to clinic on 10/16 to be checked.  Area 6'long x 3" wide.  Mild warmth to the touch.
Became extremely ill within 2 days of 2nd vaccine. First vaccine was given 11/26/2021.  Unable to eat, had fever and chills and spleen enlarged to 17 cm.  and had reactivation of EBV virus.  Had to medically withdrawal from school in Jan 2022 and lost his athletic baseball scholarship. He was told he either took the vaccine or would not be able to travel with his school baseball team, Splenomegaly continued for 8 months.  Diagnosed with Hashimoto that he never had prior to vaccine as well. No medication needed at this time as thyroid hormones were in normal range, but ultrasound showed vascularity of thyroid gland. Testicles and Lymph nodes swollen. He moved home from school and continued treatment at the Clinic until August, where he continues to follow up and also found specialists to continue care at home with Endocrinology and Gastroenterology.
Cold sweats; Hand swelling; Elbows and shoulders have been stiff and sore/His neck and knees have been painful and stiff is well; His neck and knees have been painful and stiff is well; Elbows and shoulders have been stiff and sore; Joints started hurting all over; This spontaneous case was reported by a pharmacist and describes the occurrence of COLD SWEAT (Cold sweats), PERIPHERAL SWELLING (Hand swelling), MUSCULOSKELETAL STIFFNESS (Elbows and shoulders have been stiff and sore/His neck and knees have been painful and stiff is well), NECK PAIN (His neck and knees have been painful and stiff is well) and ARTHRALGIA (Elbows and shoulders have been stiff and sore) in a 66-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 50 microgram. On 03-Oct-2023, the patient experienced COLD SWEAT (Cold sweats), PERIPHERAL SWELLING (Hand swelling), MUSCULOSKELETAL STIFFNESS (Elbows and shoulders have been stiff and sore/His neck and knees have been painful and stiff is well), NECK PAIN (His neck and knees have been painful and stiff is well), ARTHRALGIA (Elbows and shoulders have been stiff and sore) and ARTHRALGIA (Joints started hurting all over). At the time of the report, COLD SWEAT (Cold sweats), PERIPHERAL SWELLING (Hand swelling), MUSCULOSKELETAL STIFFNESS (Elbows and shoulders have been stiff and sore/His neck and knees have been painful and stiff is well) and ARTHRALGIA (Elbows and shoulders have been stiff and sore) had not resolved and NECK PAIN (His neck and knees have been painful and stiff is well) and ARTHRALGIA (Joints started hurting all over) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use), the reporter did not provide any causality assessments.   Concomitant and treatment medications were not reported.  On 03-Oct-2023, the patient's joints started hurting all over and he woke up with cold sweats. His hands also had become swollen. The patient's hand swelling persisted. He reports his elbows and shoulders have been stiff and sore. His neck and knees have been painful and stiff was well. As recent as 10/29/23 patient still had pain and swelling in his hands and was having problems not able to close his hands. It was unknown if the patient experienced any additional symptoms or events.
no adverse event; administration of improperly stored vaccines; This spontaneous report was received from a certified medical assistant and refers to a 5-year-old patient of an unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions and concomitant medications were not reported.    On 27-AUG-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rha) (PROQUAD) (dosage regimen and route of administration were not provided), lot number S021324, expiration date 05-JAN-2021, as prophylaxis. The vaccine was reconstituted using a properly stored sterile diluent (MERCK STERILE DILUENT).  The improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rha) (PROQUAD) experienced a temperature excursion of 6 degree Fahrenheit (F) to 14 F (average temperature was 10.56 F) for a period of 50 minutes. It was reported that the vaccine had a previous temperature excursion of 6 degree Fahrenheit (F) to 14 F (average temperature was 8.47 F) for a period of 30 minutes. The excursion was called by a digital data logger. No additional adverse event (AE) reported.; Sender's Comments:  US-009507513-2009USA000747: US-009507513-2009USA000777: US-009507513-2009USA000710: US-009507513-2009USA000736: US-009507513-2009USA000749: US-009507513-2009USA000757: US-009507513-2009USA000762: US-009507513-2009USA001006: US-009507513-2009USA001099: US-009507513-2009USA001114: US-009507513-2009USA001123: US-009507513-2009USA001135:
Pfizer-BioNTech COVID-19 Vaccine EUA: healthy patient training for moutain climbing expedition presented to emergency department (ED) reporting falls in the setting of new onset numbness, weakness, ataxia, paresthesias, and speech changes for a week and a half. Admitted to hospital, diagnosed with Guillain-Barre syndrome, received intravenous immune globuilin (IVIG), and transferred to physical rehabilitation program where symptoms initially improved but patient subsequently developed worsening weakness and numbness in extremities and significant dysmetria and dysarthria. Patient admitted to hospital for another course of IVIG.
Unable to raise elbow when resting. Severe pain with motion. Severe pain at night when still. Went to Dr. (Orthopedic) on 10/22/2019. Got Xrays, Medrol, Furibiprofen, and referral for Physical Therapy. Returned to Dr. 11/18/2019 for MRI. Got Cortizone shot 11/26/2019. Got Prednisone 01/13/2020.
MEDIMMUNE given to 23 mo. old too young to receive vaccine. No reaction to vaccine 4 days later.
Shaking head to toe like Parkinson's, teeth chattering, vomiting, headache, dizziness, bone pain, fever
Information has been received concerning a case in litigation, regarding an approximately 16 month old male who on 1/7/97, was vaccinated with IM with a dose of hep B vaccine (lot 619303/1282D). Other vaccines he received included a first and second IM dose of hep B vaccine, recombinant given on 11/29/95 (lot 1817A2) and 2/2/96 (lot 1943A2); four IM doses of Tetramune, given on 11/29/95, 2/2/96 (lot 429972), 4/22/96 (lot 432656), and 5/5/97 (lot 444257); one IM dose of HIB conjugate vaccine (HIBTITER) (lot M270PA) given on 5/5/97; and one IM dose of Pnu-Imune 23 (lot 441213) given on 10/20/97. It is alleged that in approximately February of 1997, at approximately 16 months of age, the pt, through exposure to the mercury laden preservative thimerasol contained in his childhood vaccinations suffered devastating, permanent, neuroilogical injuries due to mercury toxicity and associated complications and sequelae and the aggravations of other conditions directly through exposure of mercury. Upon internal review the pt's mercury toxicity and devastating, permanent neurological injuries wee considered to be other important medical events (OMIC). Additional info is expected.
Pain at injection site, including redness and swelling.  Pain in left shoulder, left side of neck and left shoulder blade down to but cheek.  Headaches, nausea since receiving injection.  Pain level has remained at 8 or higher.
Redness, warmth, and swelling of arm. Complains of pain in arm.